Oncogenes are mutated versions of normal genes (proto-oncogenes) that drive cancer growth. Targeting oncogenes can inhibit the signal transduction pathways that promote cell proliferation. For example, HER2 is an oncogene overexpressed in some breast cancers, and drugs like trastuzumab specifically target HER2 to inhibit cancer cell growth.